These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10781349)

  • 1. The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem.
    Stellbrink C; Hanrath P
    Eur Heart J; 2000 May; 21(10):795-8. PubMed ID: 10781349
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioversion of atrial fibrillation or flutter: a 'stunning' problem.
    Kamath S; Lip GY
    Eur Heart J; 2001 Mar; 22(6):520-1. PubMed ID: 11237547
    [No Abstract]   [Full Text] [Related]  

  • 3. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events.
    Grimm RA; Stewart WJ; Arheart K; Thomas JD; Klein AL
    J Am Coll Cardiol; 1997 Mar; 29(3):582-9. PubMed ID: 9060897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated.
    Densèm CG
    Am J Cardiol; 1999 Jan; 83(1):140-1. PubMed ID: 10073808
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
    Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
    Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transesophageal cardioversion of atrial flutter and atrial fibrillation using an electric balloon electrode system.
    Zheng F; Qi X; Liu H; Kang N
    Chin Med J (Engl); 2003 Sep; 116(9):1325-8. PubMed ID: 14527358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quick, easy, and safe? On the use of low-molecular-weight heparins in cardioversion of atrial fibrillation.
    Stellbrink C
    Eur Heart J; 2006 Dec; 27(23):2742-3. PubMed ID: 17098755
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prophylactic administration of anticoagulant therapy in electric cardioversion for atrial fibrillation or atrial flutter].
    Jirmár R; Gregor P
    Cor Vasa; 1993; 35(3):K81-2. PubMed ID: 8348810
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardioversion of atrial arrhythmias: audit of anticoagulation management.
    Mayet J; Wasan B; Sutton GC
    J R Coll Physicians Lond; 1997; 31(3):313-6. PubMed ID: 9192336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials.
    Moreyra E; Finkelhor RS; Cebul RD
    Am Heart J; 1995 Jan; 129(1):71-5. PubMed ID: 7817928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE).
    Santini M; De Ferrari GM; Pandozi C; Alboni P; Capucci A; Disertori M; Gaita F; Lombardi F; Maggioni AP; Mugelli A; Salerno-Uriarte JA; Sermasi S; Schwartz PJ;
    Ital Heart J; 2004 Mar; 5(3):205-13. PubMed ID: 15119503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of low-molecular-weight heparin as bridge anticoagulation therapy in patients with atrial fibrillation undergoing transoesophageal echocardiography guided cardioversion.
    Murray RD; Deitcher SR; Klein AL
    Eur Heart J; 2001 Apr; 22(8):712-3. PubMed ID: 11286529
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardioversion related thromboembolism: value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
    Seidl K; Senges J
    Card Electrophysiol Rev; 2003 Dec; 7(4):392-6. PubMed ID: 15071262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transesophageal echocardiography-guided cardioversion of atrial fibrillation.
    Grimm RA
    Echocardiography; 2000 May; 17(4):383-92. PubMed ID: 10979011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation and the cardioversion of atrial flutter.
    James PR; Hardman SM
    Int J Clin Pract; 2000; 54(1):5-6. PubMed ID: 10750250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardioversion in atrial fibrillation-and flutter].
    Steim H; Friedemann M
    Dtsch Med J; 1967 Apr; 18(7):197-208. PubMed ID: 5584806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.